Terms ending in 2040
Every in-force patent on Halozyme Hypercon, Inc.'s record whose computed term ends in 2040, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,717,488 | Particle Formation And Morphology In force · Low confidence | Halozyme Hypercon, Inc. | In force | Low confidence | |
| US 12,558,323 | Particle Formation And Morphology In force · Low confidence | Halozyme Hypercon, Inc. | In force | Low confidence | |
| US 12,263,249 | Formation of Particles Including Agents In force · High confidence | Halozyme Hypercon, Inc. | In force | High confidence | |
| US 11,654,112 | Particles Comprising a Therapeutic or Diagnostic Agent and Suspensions and Methods of Use Thereof In force · High confidence | Halozyme Hypercon, Inc. | In force | High confidence | |
| US 11,459,376 | Compositions and Methods for the Delivery of Therapeutic Biologics for Treatment of Disease In force · Low confidence | Halozyme Hypercon, Inc. | In force | Low confidence | |
| US 12,600,763 | Compositions and Methods for the Delivery of Therapeutic Biologics for Treatment of Disease In force · Medium confidence | Halozyme Hypercon, Inc. | In force | Medium confidence |
6 of 6 patents shown. Soonest term end first, then patent number.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.